Eric Warren - Aug 18, 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Commercial Officer
Signature
/s/ Sheldon L. Koenig, by power of attorney
Stock symbol
ESPR
Transactions as of
Aug 18, 2023
Transactions value $
-$344
Form type
4
Date filed
8/21/2023, 04:32 PM
Previous filing
Jul 20, 2023
Next filing
Sep 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$344 -243 -0.35% $1.41 69.1K Aug 18, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of restricted stock units.